Modeling the Impact of Comorbidity on Breast Cancer Patient Outcomes

Overview

Journal Health Care Manag Sci

Specialty Health Services

Date 2010 Jul 16

PMID 20629416

Citations 6

Authors

Shengfan Zhang

Julie Simmons Ivy

Fay Cobb Payton

Kathleen M Diehl

Affiliations

Soon will be listed here.

Abstract

The objective of this paper is to model the impact of comorbidity on breast cancer patient outcomes (e.g., length of stay and disposition). Previous studies suggest that comorbidities may significantly affect mortality risks for breast cancer patients. The 2006 AHRQ Nationwide Inpatient Sample (NIS) is used to analyze the relationships among comorbidities (e.g., hypertension, diabetes, obesity, and mental disorder), total charges, length of stay, and patient disposition as a function of age and race. A multifaceted approach is used to quantify these relationships. A causal study is performed to explore the effect of various comorbidities on patient outcomes. Least squares regression models are developed to evaluate and compare significant factors that influence total charges and length of stay. Logistic regression is used to study the factors that may cause patient mortality or transferring. In addition, different survival models are developed to study the impact of comorbidity on length of stay with censoring information. This study shows the interactions and relationship among various comorbidities and breast cancer. It shows that certain hypertension may not increase length of stay and total charges; diabetes behaves differently among general population and breast cancer patients; mental disorder has an impact on patient disposition that affects true length of stay and charges, and obesity may have limited effect on patient outcomes. Moreover, this study will help to better understand the expenditure patterns for population subgroups with several chronic conditions and to quantify the impact of comorbidities on patient outcomes. Lastly, it also provides insight for breast cancer patients with comorbidities as a function of age and race.

Citing Articles

Influence of Diabetes Mellitus on Oncological Outcomes for Patients Living With Cancer.

Murphy L, Sherifali D, Ali M, Ibrahim S Sci Diabetes Self Manag Care. 2023; 49(2):163-179.

PMID: 36789641 PMC: 10084523. DOI: 10.1177/26350106231153073.

Dynamic Risk Prediction via a Joint Frailty-Copula Model and IPD Meta-Analysis: Building Web Applications.

Emura T, Michimae H, Matsui S Entropy (Basel). 2022; 24(5).

PMID: 35626474 PMC: 9140593. DOI: 10.3390/e24050589.

Systematic review of healthcare costs related to mental health conditions among cancer survivors.

Khushalani J, Qin J, Cyrus J, Lunsford N, Rim S, Han X Expert Rev Pharmacoecon Outcomes Res. 2018; 18(5):505-517.

PMID: 29869568 PMC: 6103822. DOI: 10.1080/14737167.2018.1485097.

Hospital costs associated with psychiatric comorbidities: a retrospective study.

Wolff J, Heister T, Normann C, Kaier K BMC Health Serv Res. 2018; 18(1):67.

PMID: 29382387 PMC: 5791176. DOI: 10.1186/s12913-018-2892-5.

Diabetes and the hospitalized patient : A cluster analytic framework for characterizing the role of sex, race and comorbidity from 2006 to 2011.

Nataraj N, Ivy J, Cobb Payton F, Norman J Health Care Manag Sci. 2017; 21(4):534-553.

PMID: 28735459 DOI: 10.1007/s10729-017-9408-4.

References

Tammemagi C, Nerenz D, Neslund-Dudas C, Feldkamp C, Nathanson D . Comorbidity and survival disparities among black and white patients with breast cancer. JAMA. 2005; 294(14):1765-72. DOI: 10.1001/jama.294.14.1765. View

de Groot V, Beckerman H, Lankhorst G, Bouter L . How to measure comorbidity. a critical review of available methods. J Clin Epidemiol. 2003; 56(3):221-9. DOI: 10.1016/s0895-4356(02)00585-1. View

Zhao S, Wong J, Arguelles L . Hospitalization costs associated with leiomyoma. Clin Ther. 1999; 21(3):563-75. DOI: 10.1016/S0149-2918(00)88309-5. View

Dominick K, Dudley T, Coffman C, Bosworth H . Comparison of three comorbidity measures for predicting health service use in patients with osteoarthritis. Arthritis Rheum. 2005; 53(5):666-72. DOI: 10.1002/art.21440. View

Garis R, Farmer K . Examining costs of chronic conditions in a Medicaid population. Manag Care. 2002; 11(8):43-50. View

Starfield B, Lemke K, Bernhardt T, Foldes S, Forrest C, Weiner J . Comorbidity: implications for the importance of primary care in 'case' management. Ann Fam Med. 2004; 1(1):8-14. PMC: 1466556. DOI: 10.1370/afm.1. View

Li J . An application of lifetime models in estimation of expected length of stay of patients in hospital with complexity and age adjustment. Stat Med. 1999; 18(23):3337-44. DOI: 10.1002/(sici)1097-0258(19991215)18:23<3337::aid-sim320>3.0.co;2-5. View

Rovera F, Dionigi G, Riva C, Chiaravalli A, Corben A, Bianchi V . Identifying factors contributing to reduced breast tumor size: a longitudinal study. Int J Surg. 2009; 6 Suppl 1:S97-S100. DOI: 10.1016/j.ijsu.2008.12.011. View

Newschaffer C, Bush T, Penberthy L, Bellantoni M, Helzlsour K, Diener-West M . Does comorbid disease interact with cancer? An epidemiologic analysis of mortality in a cohort of elderly breast cancer patients. J Gerontol A Biol Sci Med Sci. 1998; 53(5):M372-8. DOI: 10.1093/gerona/53a.5.m372. View

10.

Klemi P, Parvinen I, Pylkkanen L, Kauhava L, Immonen-Raiha P, Rasanen O . Significant improvement in breast cancer survival through population-based mammography screening. Breast. 2003; 12(5):308-13. DOI: 10.1016/s0960-9776(03)00096-1. View

11.

Livingston E, Langert J . The impact of age and Medicare status on bariatric surgical outcomes. Arch Surg. 2006; 141(11):1115-20. DOI: 10.1001/archsurg.141.11.1115. View

12.

Meguid R, Brooke B, Chang D, Sherwood J, Brock M, Yang S . Are surgical outcomes for lung cancer resections improved at teaching hospitals?. Ann Thorac Surg. 2008; 85(3):1015-24. DOI: 10.1016/j.athoracsur.2007.09.046. View

13.

Holmes C, Muss H . Diagnosis and treatment of breast cancer in the elderly. CA Cancer J Clin. 2003; 53(4):227-44. DOI: 10.3322/canjclin.53.4.227. View

14.

Roehrig C, Miller G, Lake C, Bryant J . National health spending by medical condition, 1996-2005. Health Aff (Millwood). 2009; 28(2):w358-67. DOI: 10.1377/hlthaff.28.2.w358. View

15.

Suthummanon S, Omachonu V . DRG-based cost minimization models: applications in a hospital environment. Health Care Manag Sci. 2005; 7(3):197-205. DOI: 10.1023/b:hcms.0000039382.05904.c3. View

16.

Yancik R, Wesley M, Ries L, Havlik R, Edwards B, YATES J . Effect of age and comorbidity in postmenopausal breast cancer patients aged 55 years and older. JAMA. 2001; 285(7):885-92. DOI: 10.1001/jama.285.7.885. View

17.

Piccirillo J, Tierney R, Costas I, Grove L, Spitznagel Jr E . Prognostic importance of comorbidity in a hospital-based cancer registry. JAMA. 2004; 291(20):2441-7. DOI: 10.1001/jama.291.20.2441. View

18.

Farley J, Harley C, Devine J . A comparison of comorbidity measurements to predict healthcare expenditures. Am J Manag Care. 2006; 12(2):110-9. View

19.

Brandeau M, Zaric G . Optimal investment in HIV prevention programs: more is not always better. Health Care Manag Sci. 2009; 12(1):27-37. PMC: 2786080. DOI: 10.1007/s10729-008-9074-7. View

20.

Elixhauser A, Steiner C, Harris D, Coffey R . Comorbidity measures for use with administrative data. Med Care. 1998; 36(1):8-27. DOI: 10.1097/00005650-199801000-00004. View